Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CALC

CalciMedica Inc

Last Close
May 15 • 10:00AM ET
5.86
Dollar change
+0.30
Percentage change
5.50 		%
Held by: VXF VTI Scroll to Statements
Index- P/E- EPS (ttm)-2.64 Insider Own56.24% Shs Outstand5.75M Perf Week4.60%
Market Cap62.88M Forward P/E- EPS next Y-2.19 Insider Trans29.15% Shs Float4.70M Perf Month33.37%
Income-14.94M PEG- EPS next Q-0.49 Inst Own12.33% Short Float0.93% Perf Quarter11.95%
Sales0.00M P/S- EPS this Y76.01% Inst Trans1.57% Short Ratio2.08 Perf Half Y85.87%
Book/sh1.61 P/B3.65 EPS next Y-19.02% ROA-48.34% Short Interest0.04M Perf Year126.94%
Cash/sh2.39 P/C2.45 EPS next 5Y- ROE-76.09% 52W Range1.75 - 8.59 Perf YTD104.72%
Dividend Est.- P/FCF- EPS past 5Y19.56% ROI-86.62% 52W High-31.84% Beta1.30
Dividend TTM- Quick Ratio6.21 Sales past 5Y0.00% Gross Margin- 52W Low234.57% ATR (14)0.43
Dividend Ex-Date- Current Ratio6.21 EPS Y/Y TTM93.41% Oper. Margin0.00% RSI (14)63.13 Volatility6.67% 9.96%
Employees14 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price14.95
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q100.06% Payout- Rel Volume0.59 Prev Close5.55
Sales Surprise- EPS Surprise101.50% Sales Q/Q- EarningsMay 13 AMC Avg Volume20.91K Price5.86
SMA2011.11% SMA5026.49% SMA20055.24% Trades Volume1,511 Change5.50%
May-13-24 04:05PM
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
(PR Newswire) -7.14%
May-07-24 08:00AM
CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024
(PR Newswire)
Apr-24-24 08:00AM
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis
(PR Newswire) +19.61%
Apr-10-24 03:30PM
Insiders are Piling into These 10 Healthcare Stocks in 2024
(Insider Monkey)
Mar-28-24 11:53AM
CALC Stock Earnings: CalciMedica Reported Results for Q4 2023
(InvestorPlace)
07:00AM Loading…
07:00AM
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
(PR Newswire)
Mar-13-24 08:00AM
CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
(PR Newswire)
Feb-28-24 06:57PM
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
(PR Newswire)
Feb-13-24 08:00AM
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury
(PR Newswire) -8.21%
Feb-07-24 04:05PM
CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
(PR Newswire) +6.92%
Jan-22-24 08:00AM
CalciMedica Announces Private Placement of up to Approximately $55 Million
(PR Newswire) +7.09%
Dec-11-23 07:30AM
CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition
(PR Newswire) -13.88%
Nov-09-23 07:00AM
CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
(PR Newswire) -12.74%
Nov-02-23 09:15AM
CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition
(PR Newswire) +10.23%
Sep-06-23 07:30AM
CalciMedica Announces Upcoming Presentations and Events in September
(PR Newswire) +5.18%
07:30AM Loading…
Aug-31-23 07:30AM
CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023
(PR Newswire)
Aug-11-23 07:01AM
Daily Vickers Top Insider Picks for 08/11/2023
(Argus Research)
Aug-10-23 04:05PM
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
(GlobeNewswire)
06:24AM
Daily Vickers Top Insider Picks for 08/10/2023
(Argus Research)
Aug-09-23 07:30AM
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora in Acute Pancreatitis (AP)
(GlobeNewswire) +6.06%
06:26AM
Daily Vickers Top Insider Picks for 08/09/2023
(Argus Research)
Aug-08-23 06:28AM
Daily Vickers Top Insider Picks for 08/08/2023
(Argus Research)
Aug-07-23 06:35AM
Daily Vickers Top Insider Picks for 08/07/2023
(Argus Research)
Aug-04-23 07:14AM
Daily Vickers Top Insider Picks for 08/04/2023
(Argus Research)
Aug-03-23 07:15AM
Daily Vickers Top Insider Picks for 08/03/2023
(Argus Research)
Aug-02-23 07:52AM
Daily Vickers Top Insider Picks for 08/02/2023
(Argus Research)
Aug-01-23 06:51AM
Daily Vickers Top Insider Picks for 08/01/2023
(Argus Research) -6.29%
Jul-31-23 06:44AM
Daily Vickers Top Insider Picks for 07/31/2023
(Argus Research)
Jul-28-23 07:58AM
Daily Vickers Top Insider Picks for 07/28/2023
(Argus Research)
Jul-27-23 07:10AM
Daily Vickers Top Insider Picks for 07/27/2023
(Argus Research)
01:12PM Loading…
Jul-26-23 01:12PM
Daily Vickers Top Insider Picks for 07/26/2023
(Argus Research)
Jul-25-23 07:16AM
Daily Vickers Top Insider Picks for 07/25/2023
(Argus Research) -6.11%
Jul-24-23 07:12AM
Daily Vickers Top Insider Picks for 07/24/2023
(Argus Research)
Jul-21-23 07:23AM
Daily Vickers Top Insider Picks for 07/21/2023
(Argus Research)
Jul-20-23 06:55AM
Daily Vickers Top Insider Picks for 07/20/2023
(Argus Research)
Jul-19-23 07:10AM
Daily Vickers Top Insider Picks for 07/19/2023
(Argus Research)
Jul-18-23 06:53AM
Daily Vickers Top Insider Picks for 07/18/2023
(Argus Research) -5.56%
Jul-17-23 07:10AM
Daily Vickers Top Insider Picks for 07/17/2023
(Argus Research) +5.16%
Jul-14-23 06:50AM
Daily Vickers Top Insider Picks for 07/14/2023
(Argus Research)
Jul-13-23 07:02AM
Daily Vickers Top Insider Picks for 07/13/2023
(Argus Research)
Jul-12-23 07:22AM
Daily Vickers Top Insider Picks for 07/12/2023
(Argus Research) +7.08%
Jul-11-23 06:08AM
Daily Vickers Top Insider Picks for 07/11/2023
(Argus Research)
Jul-10-23 06:56AM
Daily Vickers Top Insider Picks for 07/10/2023
(Argus Research)
Jul-05-23 06:46AM
Daily Vickers Top Insider Picks for 07/05/2023
(Argus Research) +13.07%
Jul-03-23 06:50AM
Daily Vickers Top Insider Picks for 07/03/2023
(Argus Research)
Jun-30-23 06:52AM
Daily Vickers Top Insider Picks for 06/30/2023
(Argus Research) -17.32%
Jun-29-23 06:49AM
Daily Vickers Top Insider Picks for 06/29/2023
(Argus Research) +11.75%
Jun-28-23 06:58AM
Daily Vickers Top Insider Picks for 06/28/2023
(Argus Research)
Jun-27-23 06:46AM
Daily Vickers Top Insider Picks for 06/27/2023
(Argus Research) +28.00%
Jun-26-23 06:41AM
Daily Vickers Top Insider Picks for 06/26/2023
(Argus Research)
Jun-23-23 09:24AM
Daily Vickers Top Insider Picks for 06/23/2023
(Argus Research) -6.76%
Jun-12-23 07:30AM
CalciMedica Announces Relisting on Nasdaq
(GlobeNewswire)
Jun-06-23 07:30AM
CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)
(GlobeNewswire) +16.85%
May-23-23 07:30AM
CalciMedica Expands Executive Team with New Appointments
(GlobeNewswire) +9.49%
May-15-23 08:55AM
CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
(GlobeNewswire)
Mar-29-23 07:53PM
Charts Point to Higher Highs, Says Oppenheimer. Heres a Stock With Over 100% Upside Potential
(TipRanks) -8.76%
CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts Eric WCHIEF BUSINESS OFFICERApr 02 '24Buy3.903,25412,69139,894Apr 02 08:33 PM
Roberts Eric WCHIEF BUSINESS OFFICERApr 01 '24Buy3.907462,90936,640Apr 02 08:33 PM
MIDDLETON FRED ADirectorJan 23 '24Buy3.70679,3842,515,080946,744Jan 25 08:00 PM
Sanderling Venture Partners VI10% OwnerJan 23 '24Buy3.70436,0281,614,176727,433Jan 25 08:00 PM
Sanderling Venture Partners VI10% OwnerJan 23 '24Buy3.70243,356900,904946,744Jan 25 08:00 PM
WILSON ROBERT NDirectorDec 11 '23Buy3.305061,670182,161Dec 13 08:45 PM
Leheny A. RachelChief Executive OfficerNov 07 '23Buy3.342,0006,68018,840Nov 08 08:42 PM
Leheny A. RachelChief Executive OfficerNov 06 '23Buy3.122,4407,61516,840Nov 07 06:09 PM
Roberts Eric WChief Business OfficerNov 06 '23Buy3.122,4007,48835,894Nov 08 08:41 PM
Hebbar SudarshanChief Medical OfficerNov 03 '23Buy2.7436,00098,60046,000Nov 07 06:08 PM
Roberts Eric WChief Business OfficerNov 03 '23Buy2.8311,24931,84633,494Nov 07 08:42 PM
Roberts Eric WChief Business OfficerNov 03 '23Buy2.705,86015,82822,245Nov 06 06:40 PM
Leheny A. RachelChief Executive OfficerNov 03 '23Buy2.855,00014,25014,400Nov 06 06:39 PM
Roberts Eric WChief Business OfficerNov 03 '23Buy2.773,70010,24920,287Nov 07 08:42 PM
Roberts Eric WChief Business OfficerNov 03 '23Buy2.803,2008,96016,587Nov 06 06:40 PM
Roberts Eric WChief Business OfficerAug 25 '23Buy3.187362,3405,000Aug 29 07:34 PM
Roberts Eric WChief Business OfficerAug 22 '23Buy3.277142,3354,264Aug 23 06:02 PM
Roberts Eric WChief Business OfficerAug 21 '23Buy3.251,7505,6883,550Aug 23 06:02 PM
Roberts Eric WChief Business OfficerJun 26 '23Buy3.701,2004,44113,387Jun 26 08:33 PM
Roberts Eric WChief Business OfficerJun 26 '23Buy3.5320070616,385Jun 26 08:33 PM
Roberts Eric WChief Business OfficerJun 23 '23Buy3.355001,67516,185Jun 26 08:33 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.